Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The HLA-A2-supermotif: a QSAR definition.

Irini Doytchinova1, Darren Flower

  • 1Edward Jenner Institute for Vaccine Research, Compton, Berkshire, UK RG20 7NN.

Organic & Biomolecular Chemistry
|September 2, 2003
PubMed
Summary

Developing broadly applicable epitope-based vaccines is crucial. This study identified a common supermotif (FXIGXI(L)IFV) for the HLA-A2 supertype, aiding vaccine design by predicting peptide binding across multiple HLA types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rational Design, Synthesis, and Molecular Docking of Novel Terpene Analogues of Imatinib, and Their Inhibition on Downstream BCR-ABL Signaling.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Novel Indole-Based Sulfonylhydrazones as Potential Anti-Breast Cancer Agents: Synthesis, In Vitro Evaluation, ADME, and QSAR Studies.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Molecular Insights into Tumor Immunogenicity.

Current issues in molecular biology·2025
Same author

Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation.

Molecules (Basel, Switzerland)·2025
Same author

Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

AChE inhibitory activity of N-substituted natural galanthamine derivatives.

Bioorganic & medicinal chemistry letters·2024

Area of Science:

  • Immunology
  • Vaccinology
  • Computational Biology

Background:

  • Epitope-based vaccines require peptides that bind to multiple Human Leukocyte Antigen (HLA) types for broad efficacy.
  • The HLA-A2 supertype, comprising several HLA alleles, is a key target for vaccine development.

Purpose of the Study:

  • To identify a common binding motif for the HLA-A2 supertype to rationalize epitope-based vaccine development.
  • To quantitatively assess amino acid contributions at each position within nonamer peptides binding to HLA-A2-like alleles.

Main Methods:

  • A quantitative method was used to analyze over 500 nonamer peptides binding to five specific MHC alleles (A*0201, A*0202, A*0203, A*0206, A*6802).
  • The contributions of individual amino acids at each position were assessed to define a supermotif.

Main Results:

  • A supermotif, FXIGXI(L)IFV, was identified for the HLA-A2 supertype based on preferred amino acids at each position.
  • HLA-A*6802 demonstrated intermediate binding characteristics, showing affinity closer to A3 supertype at position 2 and A2 supertype at position 9.
  • Predictive models for peptide binding affinity are available online.

Conclusions:

  • The identified supermotif provides a rational basis for designing epitope-based vaccines targeting the HLA-A2 supertype.
  • Understanding HLA allele specificities, like that of HLA-A*6802, is important for optimizing vaccine strategies.
  • Computational tools can significantly aid in predicting peptide-MHC binding for vaccine development.

Related Experiment Videos